Michael Tom Clandinin
Research Interests
Michael Tom Clandinin has a total of 69 co-authors. Here are the top co-authors by number of shared publications:
A B Thomson
12 shared publicationsM Keelan
11 shared publicationsR V Rajotte
5 shared publications- Miyoung Suh
University of Manitoba
3 shared publications Alan B. R. Thomson
2 shared publicationsB J Wirzba
2 shared publications
Latest Publications
- Open Access
- 1 July 2009
- Published by American Physiological Society in American Journal of Physiology-Gastrointestinal and Liver Physiology
- Vol. 297 (1) , G52-G59
Uptake and fate of ganglioside GD3 in human intestinal Caco-2 cells
Ganglioside GD3 is a glycosphingolipid found in colostrum, developing tissues, and tumors and is known to regulate cell growth, differentiation, apoptosis, and inflammation. Feeding a GD3-enriched diet to rats increases GD3 in intestinal lipid rafts and blood. The mechanism, efficiency, and fate of ganglioside absorption by human enterocytes have not been investigated. A model to study GD3 uptake by human intestinal cells was developed to test the hypothesis that enterocyte GD3 uptake is time and concentration dependent, with uptake efficiency and fate influenced by route of delivery. Caco-2 cells were exposed to GD3 on the apical or basolateral membrane (BLM) side for 6, 24, and 48 h. GD3 uptake, retention, transfer, and metabolism was determined. GD3 uptake across the apical and BLM was time and concentration dependent and reached a plateau. GD3 uptake across the BLM was more efficient than apical delivery. Apical GD3 was metabolized with some cell retention and transfer, whereas basolateral GD3 was mostly metabolized. This study demonstrates efficient GD3 uptake by enterocytes and suggests that the route of delivery influences ganglioside uptake and fate.
- 1 July 2009
- Published by American Physiological Society in American Journal of Physiology-Gastrointestinal and Liver Physiology
- Vol. 297 (1) , G52-G59
Open AccessUptake and fate of ganglioside GD3 in human intestinal Caco-2 cells
Ganglioside GD3 is a glycosphingolipid found in colostrum, developing tissues, and tumors and is known to regulate cell growth, differentiation, apoptosis, and inflammation. Feeding a GD3-enriched diet to rats increases GD3 in intestinal lipid rafts and blood. The mechanism, efficiency, and fate of ganglioside absorption by human enterocytes have not been investigated. A model to study GD3 uptake by human intestinal cells was developed to test the hypothesis that enterocyte GD3 uptake is time and concentration dependent, with uptake efficiency and fate influenced by route of delivery. Caco-2 cells were exposed to GD3 on the apical or basolateral membrane (BLM) side for 6, 24, and 48 h. GD3 uptake, retention, transfer, and metabolism was determined. GD3 uptake across the apical and BLM was time and concentration dependent and reached a plateau. GD3 uptake across the BLM was more efficient than apical delivery. Apical GD3 was metabolized with some cell retention and transfer, whereas basolateral GD3 was mostly metabolized. This study demonstrates efficient GD3 uptake by enterocytes and suggests that the route of delivery influences ganglioside uptake and fate.
- 1 February 2009
- Published by Taylor & Francis in Journal of the American College of Nutrition
- Vol. 28 (1) , 7-15
Dietary Assessment of Arachidonic Acid and Docosahexaenoic Acid Intake in 4–7 Year-Old Children
Objective: To investigate current dietary intakes of arachidonic acid (AA), docosahexaenoic acid (DHA) in healthy children between 4–7 years of age using a 3-day food record. Design: Cross-sectional study investigating dietary intakes using food records. Parents were instructed to document all food and drink consumed by their child for 3 consecutive days. Subjects and Setting: Healthy children (n = 91), 4–7 years of age, living in central Alberta, Canada were volunteered by their parents to participate in the study. Seventy-eight children completed the study. Results: AA and DHA intakes were 57 ± 35 mg/day and 37 ± 63 mg/day, ranged between 1.2–180 mg/day and 0–350 mg/day and varied day to day at 0–380 mg/day and 0–991 mg/d, respectively. DHA intake was ≤30 mg/day for 74% of the subjects. Conclusion: Canadian children, 4–7 years of age and not living near a marine environment, have relatively low dietary intakes of AA and DHA. Retinal and neuronal development continues throughout childhood, therefore it is conceivable that low intake of AA and DHA may have a negative impact.
- 1 February 2009
- Published by Taylor & Francis in Journal of the American College of Nutrition
- Vol. 28 (1) , 7-15
Dietary Assessment of Arachidonic Acid and Docosahexaenoic Acid Intake in 4–7 Year-Old Children
Objective: To investigate current dietary intakes of arachidonic acid (AA), docosahexaenoic acid (DHA) in healthy children between 4–7 years of age using a 3-day food record. Design: Cross-sectional study investigating dietary intakes using food records. Parents were instructed to document all food and drink consumed by their child for 3 consecutive days. Subjects and Setting: Healthy children (n = 91), 4–7 years of age, living in central Alberta, Canada were volunteered by their parents to participate in the study. Seventy-eight children completed the study. Results: AA and DHA intakes were 57 ± 35 mg/day and 37 ± 63 mg/day, ranged between 1.2–180 mg/day and 0–350 mg/day and varied day to day at 0–380 mg/day and 0–991 mg/d, respectively. DHA intake was ≤30 mg/day for 74% of the subjects. Conclusion: Canadian children, 4–7 years of age and not living near a marine environment, have relatively low dietary intakes of AA and DHA. Retinal and neuronal development continues throughout childhood, therefore it is conceivable that low intake of AA and DHA may have a negative impact.
- Open Access
- 20 August 2008
- Published by Cambridge University Press (CUP) in British Journal of Nutrition
- Vol. 101 (5) , 694-700
Ganglioside composition of differentiated Caco-2 cells resembles human colostrum and neonatal rat intestine
Gangliosides are glycosphingolipids found in cell membranes and human milk with important roles in cell proliferation, differentiation, growth, adhesion, migration, signalling and apoptosis. Similar changes in ganglioside composition occur during embryonic development, lactation and cancer cell differentiation. It is not known, however, whether ganglioside compositional changes that occur in differentiating colon cancer cells reflect changes that occur during intestinal development. The Caco-2 cell line is commonly used to study physiological and pathophysiological processes in the small intestine and colon. Therefore, to examine this question, undifferentiated and differentiated Caco-2 cells were grown and total lipid was extracted from cell supernatant fractions using the Folch method. The upper aqueous phase containing gangliosides was collected and purified. Total gangliosides were measured as ganglioside-bound N-acetyl neuraminic acid, while individual ganglioside content was quantified via a colorimetric assay for sialic acid and scanning densitometry. The total ganglioside content of differentiated Caco-2 cells was 2·5 times higher compared with undifferentiated cells. Differentiated Caco-2 cells had significantly more (N-acetylneuraminyl) 2-galactosylglucosyl ceramide (GD3) and polar gangliosides, and a lower N-acetylneuraminylgalactosylglucosylceramide (GM3):GD3ratio than undifferentiated cells. The present study demonstrates that the total ganglioside content and individual ganglioside composition of differentiated Caco-2 cells are similar to those of human colostrum and neonatal rat intestine. Differentiated Caco-2 cells may therefore be an alternative model for studying physiological and pathological processes in the small intestine and colon, and may help to elucidate possible functions for specific gangliosides in development and differentiation. Further research using more sensitive techniques of ganglioside analysis is needed to confirm these findings.
- 20 August 2008
- Published by Cambridge University Press (CUP) in British Journal of Nutrition
- Vol. 101 (5) , 694-700
Open AccessGanglioside composition of differentiated Caco-2 cells resembles human colostrum and neonatal rat intestine
Gangliosides are glycosphingolipids found in cell membranes and human milk with important roles in cell proliferation, differentiation, growth, adhesion, migration, signalling and apoptosis. Similar changes in ganglioside composition occur during embryonic development, lactation and cancer cell differentiation. It is not known, however, whether ganglioside compositional changes that occur in differentiating colon cancer cells reflect changes that occur during intestinal development. The Caco-2 cell line is commonly used to study physiological and pathophysiological processes in the small intestine and colon. Therefore, to examine this question, undifferentiated and differentiated Caco-2 cells were grown and total lipid was extracted from cell supernatant fractions using the Folch method. The upper aqueous phase containing gangliosides was collected and purified. Total gangliosides were measured as ganglioside-bound N-acetyl neuraminic acid, while individual ganglioside content was quantified via a colorimetric assay for sialic acid and scanning densitometry. The total ganglioside content of differentiated Caco-2 cells was 2·5 times higher compared with undifferentiated cells. Differentiated Caco-2 cells had significantly more (N-acetylneuraminyl) 2-galactosylglucosyl ceramide (GD3) and polar gangliosides, and a lower N-acetylneuraminylgalactosylglucosylceramide (GM3):GD3ratio than undifferentiated cells. The present study demonstrates that the total ganglioside content and individual ganglioside composition of differentiated Caco-2 cells are similar to those of human colostrum and neonatal rat intestine. Differentiated Caco-2 cells may therefore be an alternative model for studying physiological and pathological processes in the small intestine and colon, and may help to elucidate possible functions for specific gangliosides in development and differentiation. Further research using more sensitive techniques of ganglioside analysis is needed to confirm these findings.
- Open Access
- 1 January 2008
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 14 (14) , 2142-2161
Necrotizing enterocolitis: A multifactorial disease with no cure
Necrotizing enterocolitis: A multifactorial disease with no cure
- 1 January 2008
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 14 (14) , 2142-2161
Open AccessNecrotizing enterocolitis: A multifactorial disease with no cure
Necrotizing enterocolitis: A multifactorial disease with no cure
- Open Access
- 1 August 2007
- Published by Cambridge University Press (CUP) in British Journal of Nutrition
- Vol. 98 (2) , 337-344
Cholesterolaemic influence of palmitic acid in thesn-1, 3v.thesn-2 position with high or low dietary linoleic acid in healthy young men
Healthy young men were fed four diets for 2 weeks each providing natural fats containing palmitic acid (16 : 0) predominantly in thesn-1, 3 position of dietary TAG or containing 16 : 0 predominantly in thesn-2 position with low or high levels of linoleic acid (18 : 2n-6). Two treatments supplied 16 : 0 in thesn-1, 3 positions from palmstearin with low (3 % energy) or high (>7 % energy) 18 : 2n-6 and two treatments supplied 16 : 0 in thesn-2 position from lard with high or low levels of 18 : 2n-6. Diets contained 30–35 % energy as fat, 7–11 % energy as 16 : 0 and moderate levels of cholesterol. Fasting serum cholesterol and lipoprotein concentrations were measured. Cholesterol fractional synthesis rate (FSR) was determined by2H incorporation. Diets providing 16 : 0 in thesn-2 position resulted in lower fasting serum total cholesterol (TC) and a lower TC:HDL ratio than diets providing 16 : 0 in thesn-1, 3 positions. Diets with high levels of 18 : 2n-6 significantly decreased the TC:HDL ratio, reaffirming the well-known cholesterol-reducing effect of 18 : 2n-6. A lower non-esterified cholesterol FSR was observed with low dietary levels of 18 : 2n-6. No differences between dietary treatments were found for serum HDL-cholesterol, LDL-cholesterol or TAG. It is concluded that dietary fats containing 16 : 0 in thesn-2 position may result in slightly lower fasting TC than diets providing 16 : 0 in thesn-1, 3 positions, while the level ofn-6 polyunsaturated fat influences endogenous cholesterol synthesis.
- 1 August 2007
- Published by Cambridge University Press (CUP) in British Journal of Nutrition
- Vol. 98 (2) , 337-344
Open AccessCholesterolaemic influence of palmitic acid in thesn-1, 3v.thesn-2 position with high or low dietary linoleic acid in healthy young men
Healthy young men were fed four diets for 2 weeks each providing natural fats containing palmitic acid (16 : 0) predominantly in thesn-1, 3 position of dietary TAG or containing 16 : 0 predominantly in thesn-2 position with low or high levels of linoleic acid (18 : 2n-6). Two treatments supplied 16 : 0 in thesn-1, 3 positions from palmstearin with low (3 % energy) or high (>7 % energy) 18 : 2n-6 and two treatments supplied 16 : 0 in thesn-2 position from lard with high or low levels of 18 : 2n-6. Diets contained 30–35 % energy as fat, 7–11 % energy as 16 : 0 and moderate levels of cholesterol. Fasting serum cholesterol and lipoprotein concentrations were measured. Cholesterol fractional synthesis rate (FSR) was determined by2H incorporation. Diets providing 16 : 0 in thesn-2 position resulted in lower fasting serum total cholesterol (TC) and a lower TC:HDL ratio than diets providing 16 : 0 in thesn-1, 3 positions. Diets with high levels of 18 : 2n-6 significantly decreased the TC:HDL ratio, reaffirming the well-known cholesterol-reducing effect of 18 : 2n-6. A lower non-esterified cholesterol FSR was observed with low dietary levels of 18 : 2n-6. No differences between dietary treatments were found for serum HDL-cholesterol, LDL-cholesterol or TAG. It is concluded that dietary fats containing 16 : 0 in thesn-2 position may result in slightly lower fasting TC than diets providing 16 : 0 in thesn-1, 3 positions, while the level ofn-6 polyunsaturated fat influences endogenous cholesterol synthesis.
- 1 July 2007
- Published by Wolters Kluwer Health in Shock
- Vol. 28 (1) , 112-117
DIETARY GANGLIOSIDE INHIBITS ACUTE INFLAMMATORY SIGNALS IN INTESTINAL MUCOSA AND BLOOD INDUCED BY SYSTEMIC INFLAMMATION OF ESCHERICHIA COLI LIPOPOLYSACCHARIDE
Our previous study demonstrated that feeding ganglioside increased total ganglioside content while decreasing cholesterol and caveolin-1 content in developing rat intestinal lipid microdomains. Cholesterol or caveolin depletion in membranes inhibits inflammatory signaling by disrupting microdomain structure. We hypothesized that dietary ganglioside-induced reduction in cholesterol content will reduce proinflammatory mediators in the intestinal mucosa after acute exposure to bacterial endotoxin. Weanling rats were fed semipurified diets with 0.1% (wt/wt of total fat) gangliosides (treatment) or without ganglioside (control). After 2 weeks of feeding, half of animals from each diet group were injected with saline or lipopolysaccharide (LPS) endotoxin (Escherichia coli serotype O111:B4, intraperitoneal, 3 mg/kg body weight) to induce acute gut inflammation. Intestinal mucosa and blood were collected after 6 h. The effect of dietary ganglioside on proinflammatory mediators including cholesterol, platelet-activating factor, prostaglandin E2, leukotriene B4 (LTB4), interleukin-1β (IL-1β), and tumor necrosis factor-α (TNF-α) was determined in inflamed mucosa and blood. Feeding animals the control diet increased cholesterol content in intestinal lipid microdomains by 92% after LPS injection compared with saline injection. Animals fed the ganglioside diet significantly decreased cholesterol content in lipid microdomains by 60% compared with animals fed the control diet. Feeding animals the ganglioside diet increased total ganglioside content by 90% while decreasing platelet-activating factor content by 45% in the inflamed mucosa by acute systemic exposure to LPS compared with animals fed the control diet. When animals were fed the ganglioside diet, the levels of prostaglandin E2, LTB4, IL-1β, and TNF-α were lower in inflamed mucosa, and LTB4, IL-1β, and TNF-α were decreased in plasma by 41%, 58%, and 55% compared with control animals, respectively. The present study demonstrates that dietary gangliosides inhibit proinflammatory signals in the intestine and blood induced by acute inflammation of LPS and suggests therapeutic potential in the treatment and management of acute local and systemic inflammatory diseases.
- 1 July 2007
- Published by Wolters Kluwer Health in Shock
- Vol. 28 (1) , 112-117
DIETARY GANGLIOSIDE INHIBITS ACUTE INFLAMMATORY SIGNALS IN INTESTINAL MUCOSA AND BLOOD INDUCED BY SYSTEMIC INFLAMMATION OF ESCHERICHIA COLI LIPOPOLYSACCHARIDE
Our previous study demonstrated that feeding ganglioside increased total ganglioside content while decreasing cholesterol and caveolin-1 content in developing rat intestinal lipid microdomains. Cholesterol or caveolin depletion in membranes inhibits inflammatory signaling by disrupting microdomain structure. We hypothesized that dietary ganglioside-induced reduction in cholesterol content will reduce proinflammatory mediators in the intestinal mucosa after acute exposure to bacterial endotoxin. Weanling rats were fed semipurified diets with 0.1% (wt/wt of total fat) gangliosides (treatment) or without ganglioside (control). After 2 weeks of feeding, half of animals from each diet group were injected with saline or lipopolysaccharide (LPS) endotoxin (Escherichia coli serotype O111:B4, intraperitoneal, 3 mg/kg body weight) to induce acute gut inflammation. Intestinal mucosa and blood were collected after 6 h. The effect of dietary ganglioside on proinflammatory mediators including cholesterol, platelet-activating factor, prostaglandin E2, leukotriene B4 (LTB4), interleukin-1β (IL-1β), and tumor necrosis factor-α (TNF-α) was determined in inflamed mucosa and blood. Feeding animals the control diet increased cholesterol content in intestinal lipid microdomains by 92% after LPS injection compared with saline injection. Animals fed the ganglioside diet significantly decreased cholesterol content in lipid microdomains by 60% compared with animals fed the control diet. Feeding animals the ganglioside diet increased total ganglioside content by 90% while decreasing platelet-activating factor content by 45% in the inflamed mucosa by acute systemic exposure to LPS compared with animals fed the control diet. When animals were fed the ganglioside diet, the levels of prostaglandin E2, LTB4, IL-1β, and TNF-α were lower in inflamed mucosa, and LTB4, IL-1β, and TNF-α were decreased in plasma by 41%, 58%, and 55% compared with control animals, respectively. The present study demonstrates that dietary gangliosides inhibit proinflammatory signals in the intestine and blood induced by acute inflammation of LPS and suggests therapeutic potential in the treatment and management of acute local and systemic inflammatory diseases.
- Open Access
- 1 July 2005
- Published by Association for Research in Vision and Ophthalmology (ARVO) in Investigative Ophthalmology & Visual Science
- Vol. 46 (7) , 2571-2575
Dietary Ganglioside and Long-Chain Polyunsaturated Fatty Acids Increase Ganglioside GD3 Content and Alter the Phospholipid Profile in Neonatal Rat Retina
Purpose. During early development, the ganglioside composition of the retina changes significantly, in that GD3 becomes the primary ganglioside in the mammalian retina. Because gangliosides play an important role in neuronal cell differentiation and proliferation, this change in ganglioside profile may indicate retinal maturation. Dietary long-chain polyunsaturated fatty acids (LCPs) such as 20:4n-6 and 22:6n-3 improve visual acuity in infants. Dietary LCPs stimulate neonatal retinal development by altering membrane phospholipids, which in turn affect cell signaling pathways. It is unknown whether dietary ganglioside and LCPs affect the metabolism of phospholipids and gangliosides during retinal development. methods. Male Sprague-Dawley rats (18 days old) were fed semipurified diets consisting of 20% fat (control diet) for 2 weeks containing either 0.1% ganglioside enriched in GD3 (GG diet) or 1% 20:4n-6 and 0.5% 22:6n-3 (LCP diet) in the control diet. The profile of ganglioside and phospholipid was measured. results. The GG diet increased the ganglioside content by 39% in the retina, with a relative increase in GD3 (by 13%). Dietary LCPs significantly increased the relative levels of GD3 (by 19%, P < 0.01). Total phospholipid was decreased by the LCP-supplemented diet (by 28%). Phosphatidylcholine and phosphatidylserine increased with concomitant decreases in phosphatidylinositol and lyso-phosphatidylethanolamine when animals were fed either the LCP or the GG diet. conclusions. Animals fed dietary ganglioside increased in total retinal ganglioside and GD3 content during retinal development, with a concomitant alteration of phospholipid metabolism. Feeding animals dietary LCPs also affected ganglioside metabolism in the developing retina, suggesting a new mechanism by which these dietary lipids may promote maturation of photoreceptor cells.
- 1 July 2005
- Published by Association for Research in Vision and Ophthalmology (ARVO) in Investigative Ophthalmology & Visual Science
- Vol. 46 (7) , 2571-2575
Open AccessDietary Ganglioside and Long-Chain Polyunsaturated Fatty Acids Increase Ganglioside GD3 Content and Alter the Phospholipid Profile in Neonatal Rat Retina
Purpose. During early development, the ganglioside composition of the retina changes significantly, in that GD3 becomes the primary ganglioside in the mammalian retina. Because gangliosides play an important role in neuronal cell differentiation and proliferation, this change in ganglioside profile may indicate retinal maturation. Dietary long-chain polyunsaturated fatty acids (LCPs) such as 20:4n-6 and 22:6n-3 improve visual acuity in infants. Dietary LCPs stimulate neonatal retinal development by altering membrane phospholipids, which in turn affect cell signaling pathways. It is unknown whether dietary ganglioside and LCPs affect the metabolism of phospholipids and gangliosides during retinal development. methods. Male Sprague-Dawley rats (18 days old) were fed semipurified diets consisting of 20% fat (control diet) for 2 weeks containing either 0.1% ganglioside enriched in GD3 (GG diet) or 1% 20:4n-6 and 0.5% 22:6n-3 (LCP diet) in the control diet. The profile of ganglioside and phospholipid was measured. results. The GG diet increased the ganglioside content by 39% in the retina, with a relative increase in GD3 (by 13%). Dietary LCPs significantly increased the relative levels of GD3 (by 19%, P < 0.01). Total phospholipid was decreased by the LCP-supplemented diet (by 28%). Phosphatidylcholine and phosphatidylserine increased with concomitant decreases in phosphatidylinositol and lyso-phosphatidylethanolamine when animals were fed either the LCP or the GG diet. conclusions. Animals fed dietary ganglioside increased in total retinal ganglioside and GD3 content during retinal development, with a concomitant alteration of phospholipid metabolism. Feeding animals dietary LCPs also affected ganglioside metabolism in the developing retina, suggesting a new mechanism by which these dietary lipids may promote maturation of photoreceptor cells.
- 4 November 2002
- Published by Wiley in Journal of Neurochemistry
- Vol. 83 (4) , 764-774
Dietary low linolenic acid compared with docosahexaenoic acid alter synaptic plasma membrane phospholipid fatty acid composition and sodium–potassium ATPase kinetics in developing rats
The objective of this study was to investigate if maternal dietary 20:4n‐6 arachidonic acid (AA) and 22:6n‐3 compared with adequate or low levels of 18:3n‐3 linolenic acid (LNA) increases synaptic plasma membrane (SPM) cholesterol and phospholipid content, phospholipid 20:4n‐6 and 22:6n‐3 content, and Na,K‐ATPase kinetics in rat pups at two and five weeks of age. At parturition, Sprague‐Dawley rats were fed semi‐purified diets containing either AA + docosahexaenoic acid (DHA), adequate LNA (control; 18:2n‐6 : 18:3n‐3 ratio of 7.1 : 1) or low LNA (18:2n‐6 : 18:3n‐39 ratio of 835 : 1). During the first two weeks of life, the rat pups received only their dams' milk. After weaning, pups received the same diet as their respective dams to five weeks of age. No significant difference was observed among rat pups fed the diet treatments for SPM cholesterol or total and individual phospholipid content at two and five weeks of age. Fatty acid analysis revealed that maternal dietary AA + DHA, compared with feeding the dams the control diet or the low LNA diet, increased 20:4n‐6 in phosphatidylserine and 22:6n‐3 content of SPM phospholipids. Rats fed dietary AA + DHA or the control diet exhibited a significantly increased Vmax for SPM Na,K‐ATPase. Diet treatment did not alter the Km (affinity) of SPM Na,K‐ATPase in rat pups at two and five weeks of age. It is concluded that dietary AA + DHA does not alter SPM cholesterol and phospholipid content but increases the 22:6n‐3 content of SPM phospholipids modulating activity of Na,K‐ATPase.
- 4 November 2002
- Published by Wiley in Journal of Neurochemistry
- Vol. 83 (4) , 764-774
Dietary low linolenic acid compared with docosahexaenoic acid alter synaptic plasma membrane phospholipid fatty acid composition and sodium–potassium ATPase kinetics in developing rats
The objective of this study was to investigate if maternal dietary 20:4n‐6 arachidonic acid (AA) and 22:6n‐3 compared with adequate or low levels of 18:3n‐3 linolenic acid (LNA) increases synaptic plasma membrane (SPM) cholesterol and phospholipid content, phospholipid 20:4n‐6 and 22:6n‐3 content, and Na,K‐ATPase kinetics in rat pups at two and five weeks of age. At parturition, Sprague‐Dawley rats were fed semi‐purified diets containing either AA + docosahexaenoic acid (DHA), adequate LNA (control; 18:2n‐6 : 18:3n‐3 ratio of 7.1 : 1) or low LNA (18:2n‐6 : 18:3n‐39 ratio of 835 : 1). During the first two weeks of life, the rat pups received only their dams' milk. After weaning, pups received the same diet as their respective dams to five weeks of age. No significant difference was observed among rat pups fed the diet treatments for SPM cholesterol or total and individual phospholipid content at two and five weeks of age. Fatty acid analysis revealed that maternal dietary AA + DHA, compared with feeding the dams the control diet or the low LNA diet, increased 20:4n‐6 in phosphatidylserine and 22:6n‐3 content of SPM phospholipids. Rats fed dietary AA + DHA or the control diet exhibited a significantly increased Vmax for SPM Na,K‐ATPase. Diet treatment did not alter the Km (affinity) of SPM Na,K‐ATPase in rat pups at two and five weeks of age. It is concluded that dietary AA + DHA does not alter SPM cholesterol and phospholipid content but increases the 22:6n‐3 content of SPM phospholipids modulating activity of Na,K‐ATPase.